Nanomedicine for oral chemotherapy

Nanomedicine (Lond). 2011 Apr;6(3):407-10. doi: 10.2217/nnm.11.7.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / antagonists & inhibitors
  • Administration, Oral*
  • Anticarcinogenic Agents / administration & dosage*
  • Cyclosporine / administration & dosage
  • Cyclosporine / adverse effects
  • Cytochrome P-450 Enzyme Inhibitors
  • Drug Resistance, Multiple
  • Drug Therapy / methods*
  • Humans
  • Nanomedicine / methods*
  • Paclitaxel / administration & dosage
  • Ritonavir / administration & dosage
  • Ritonavir / adverse effects

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Anticarcinogenic Agents
  • Cytochrome P-450 Enzyme Inhibitors
  • Cyclosporine
  • Ritonavir
  • Paclitaxel